Tyler Y Kang - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Tyler Y Kang

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Journal of Neuro-Oncology|April 29, 2008

Irinotecan and bevacizumab in progressive primary brain tumors, an evaluation of efficacy and safetyTyler Y Kang, Tony Jin, Heinrich Elinzano, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2006

Thalidomide use and digital gangreneTyler Y Kang, Christopher J Lowe, Mikkael A Sekeres

BJU International|January 25, 2007

Functional heterogeneity of prostatic intraepithelial neoplasia: the duration of hormonal therapy influences the responseTyler Y Kang, Peter Nichols, Eila Skinner, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Journal of Neuro-Oncology|April 29, 2008

Irinotecan and bevacizumab in progressive primary brain tumors, an evaluation of efficacy and safetyTyler Y Kang, Tony Jin, Heinrich Elinzano, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2006

Thalidomide use and digital gangreneTyler Y Kang, Christopher J Lowe, Mikkael A Sekeres

BJU International|January 25, 2007

Functional heterogeneity of prostatic intraepithelial neoplasia: the duration of hormonal therapy influences the responseTyler Y Kang, Peter Nichols, Eila Skinner, et al.

Pageof 1